BioCentury | Jul 21, 2008
Clinical News

MT001: Phase I start

...In 2Q09, Madeira plans to begin a U.S. Phase I trial in healthy pediatric volunteers. Madeira Therapeutics LLC...
BioCentury | Jun 30, 2008
Company News

Madeira board of directors update

Madeira Therapeutics LLC , Leawood, Kan. Business: Metabolic, Neurology, Endocrine Appointed: J. Lyle Bootman, dean of University of Arizona College of Pharmacy WIR Staff Neurology...
Items per page:
1 - 2 of 2
BioCentury | Jul 21, 2008
Clinical News

MT001: Phase I start

...In 2Q09, Madeira plans to begin a U.S. Phase I trial in healthy pediatric volunteers. Madeira Therapeutics LLC...
BioCentury | Jun 30, 2008
Company News

Madeira board of directors update

Madeira Therapeutics LLC , Leawood, Kan. Business: Metabolic, Neurology, Endocrine Appointed: J. Lyle Bootman, dean of University of Arizona College of Pharmacy WIR Staff Neurology...
Items per page:
1 - 2 of 2